$AVNI
ARVANA INC Stock $avni

$avni Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000160706224000118 Filed on April 05, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$13.83K	$640.00	$24.28K
YoY Change	1.85%
Cost Of Revenue	$15.76K	$9.720K	$50.65K
YoY Change	7.72%	-67.28%	70.48%
Gross Profit	-$1.930K	-$9.080K	-$26.37K
YoY Change	83.81%	-69.44%	-11.24%
Gross Profit Margin	-13.96%	-1418.75%	-108.61%
Selling, General & Admin	$129.8K	$140.2K	$504.5K
YoY Change	19.39%	117.28%	270.66%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.711K	$6.420K	$23.97K
YoY Change	14.7%
% of Gross Profit
Operating Expenses	$152.2K	$140.2K	$504.6K
YoY Change	23.44%	117.28%	204.26%
Operating Profit	-$138.4K	-$149.3K	-$530.9K
YoY Change	26.12%	58.41%	220.16%
Interest Expense	-$19.42K	-$15.89K	-$58.64K
YoY Change	-217.53%	-79550.0%	-10089.78%
% of Operating Profit
Other Income/Expense, Net	-$7.414K	$12.00K	$44.00K
YoY Change	63.95%		204.81%
Pretax Income	-$145.8K	-$153.2K	-$1.317M
YoY Change	27.61%	62.58%	769.62%
Income Tax
% Of Pretax Income
Net Earnings	-$145.8K	-$153.2K	-$1.317M
YoY Change	27.61%	62.58%	769.62%
Net Earnings / Revenue	-1054.4%	-23934.38%	-5422.45%
Basic Earnings Per Share	$0.00		-$0.01
Diluted Earnings Per Share	$0.00	$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	107.8M shares	107.8M shares	107.8M shares
Diluted Shares Outstanding	107.8M shares		107.8M shares

Balance Sheet

Concept	2024 Q2	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.23K	$22.07K
YoY Change	-12.98%	-84.5%
Cash & Equivalents	$16.23K	$22.07K
Short-Term Investments
Other Short-Term Assets	$5.100K	$5.100K
YoY Change	0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$21.33K	$27.17K
YoY Change	-10.21%	-80.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$150.0K	$163.4K
YoY Change	-10.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$176.0K	$189.4K
YoY Change	-8.83%
TOTAL ASSETS
Total Short-Term Assets	$21.33K	$27.17K
Total Long-Term Assets	$176.0K	$189.4K
Total Assets	$197.3K	$216.6K
YoY Change	-8.98%	52.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$72.35K	$147.1K
YoY Change	7.71%	288.3%
Accrued Expenses		$100.8K
YoY Change		238.76%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$781.3K	$191.4K
YoY Change	1945.68%
Total Short-Term Liabilities	$1.204M	$338.5K
YoY Change	823.29%	793.82%
LONG-TERM LIABILITIES
Long-Term Debt	$125.8K	$840.2K
YoY Change	-85.83%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$125.8K	$840.2K
YoY Change	-85.83%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.204M	$338.5K
Total Long-Term Liabilities	$125.8K	$840.2K
Total Liabilities	$1.329M	$1.179M
YoY Change	30.59%	3012.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$37.83M	-$37.56M
YoY Change	1.47%	3.63%
Common Stock	$36.70M	$36.60M
YoY Change	0.6%	0.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.336K	$3.336K
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	-$1.132M	-$962.1K
YoY Change
Total Liabilities & Shareholders Equity	$197.3K	$216.6K
YoY Change	-8.98%	52.11%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$145.8K	-$153.2K	-$1.317M
YoY Change	27.61%	62.58%	769.62%
Depreciation, Depletion And Amortization	$6.711K	$6.420K	$23.97K
YoY Change	14.7%
Cash From Operating Activities	-$176.3K	-$57.35K	-$206.1K
YoY Change	219.54%	-19.02%	55.39%
INVESTING ACTIVITIES
Capital Expenditures		$2.900K	$8.640K
YoY Change
Acquisitions			-$4.089K
YoY Change
Other Investing Activities	$0.00	$0.00	-$45.91K
YoY Change
Cash From Investing Activities	$0.00	-$2.900K	-$54.55K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	58.47K	79.03K	140.4K
YoY Change	162.55%	-9737.8%	-48.33%
NET CHANGE
Cash From Operating Activities	-176.3K	-57.35K	-206.1K
Cash From Investing Activities	0.000	-2.900K	-54.55K
Cash From Financing Activities	58.47K	79.03K	140.4K
Net Change In Cash	-117.8K	18.78K	-120.3K
YoY Change	258.12%	-126.21%	-186.52%
FREE CASH FLOW
Cash From Operating Activities	-$176.3K	-$57.35K	-$206.1K
Capital Expenditures		$2.900K	$8.640K
Free Cash Flow		-$60.25K	-$214.8K
YoY Change			61.9%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001113313
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	AVNI	Notes Payable Related Party Classified Current NotesPayableRelatedPartyClassifiedCurrent		usd
CY2022	AVNI	Revenues Charter Income RevenuesCharterIncome		usd
CY2022	us-gaap	Revenues Revenues		usd
CY2022	AVNI	Charter Expenses CharterExpenses		usd
CY2022	us-gaap	Lease Income LeaseIncome		usd
CY2023	us-gaap	Other Income OtherIncome		usd
CY2022	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1		usd
CY2022	us-gaap	Depreciation Depreciation		usd
CY2022	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1		usd
CY2022	AVNI	Payments To Acquire Fixed Assets PaymentsToAcquireFixedAssets		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	AVNI	Proceeds From Loans Payable ProceedsFromLoansPayable		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	AVNI	Incurred Share Issuance Costs IncurredShareIssuanceCosts		usd
CY2023	AVNI	Related Party Payable Reduced Through Issuance Of Shares RelatedPartyPayableReducedThroughIssuanceOfShares		usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1		usd
CY2022Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	0-30695
CY2023	dei	Entity Registrant Name EntityRegistrantName	ARVANA INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0618509
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	299 Main Street
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	13th Floor
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Salt Lake City
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84111
CY2023	dei	City Area Code CityAreaCode	(801)
CY2023	dei	Local Phone Number LocalPhoneNumber	232-7395
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	20095923	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	107845554	shares
CY2023	AVNI	Auditor Location2 AuditorLocation2	Margate, Florida
CY2023	AVNI	Auditor Firm Id2 AuditorFirmId2	5036
CY2023	AVNI	Auditor Name2 AuditorName2	ASSURANCE DIMENSIONS
CY2023	dei	Auditor Location AuditorLocation	Vancouver, Canada
CY2023	dei	Auditor Name AuditorName	DAVIDSON & COMPANY LLP
CY2023	dei	Auditor Firm AuditorFirmId	731
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	22071	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	142365	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	5100	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	0	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	27171	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	142365	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	163378	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	26000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	189378	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	0	usd
CY2023Q4	us-gaap	Assets Assets	216549	usd
CY2022Q4	us-gaap	Assets Assets	142365	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	100849	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29770	usd
CY2023Q4	AVNI	Due To Related Party Current DueToRelatedPartyCurrent	46200	usd
CY2022Q4	AVNI	Due To Related Party Current DueToRelatedPartyCurrent	8100	usd
CY2023Q4	AVNI	Notes Payable Related Party Classified Current NotesPayableRelatedPartyClassifiedCurrent	112000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	79438	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	338487	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	37870	usd
CY2023Q4	AVNI	Notes Payable Noncurrent NotesPayableNoncurrent	840188	usd
CY2022Q4	AVNI	Notes Payable Noncurrent NotesPayableNoncurrent	0	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	840188	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	0	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1178675	usd
CY2022Q4	us-gaap	Liabilities Liabilities	37870	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	107845554	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	107845554	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	107839299	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	107839299	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	107847	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	107847	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	36490304	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	36240352	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37556941	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36240368	usd
CY2023Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	-958790	usd
CY2022Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	107831	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	6255	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3336	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3336	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-962126	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	104495	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	216549	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	142365	usd
CY2023	AVNI	Revenues Charter Income RevenuesCharterIncome	24276	usd
CY2023	us-gaap	Revenues Revenues	24276	usd
CY2023	AVNI	Charter Expenses CharterExpenses	50654	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	403528	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	320000	usd
CY2022	AVNI	Incurred Share Issuance Costs IncurredShareIssuanceCosts	-32237	usd
CY2023	us-gaap	Payments For Loans PaymentsForLoans	20990	usd
CY2022	us-gaap	Payments For Loans PaymentsForLoans	15500	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	140376	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	272263	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-120294	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	139025	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	142365	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	100145	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	101016	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	65686	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	555198	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	165831	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-530922	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-165831	usd
CY2023	us-gaap	Lease Income LeaseIncome	44000	usd
CY2023	us-gaap	Interest Income Operating InterestIncomeOperating	5	usd
CY2022	us-gaap	Interest Income Operating InterestIncomeOperating	22	usd
CY2023	us-gaap	Interest Expense InterestExpense	58647	usd
CY2022	us-gaap	Interest Expense InterestExpense	587	usd
CY2022	us-gaap	Other Income OtherIncome	15000	usd
CY2023	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	771009	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-785651	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	14435	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1316573	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-151396	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107839299	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107839299	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107839299	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107839299	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-101585	usd
CY2022	AVNI	Issuance Of Common Stock IssuanceOfCommonStock	4800000	shares
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	320000	usd
CY2022	AVNI	Incurred Share Issuance Costs IncurredShareIssuanceCosts	-32237	usd
CY2022	AVNI	Conversion Of Related Party Debt To Equity Shares ConversionOfRelatedPartyDebtToEquityShares	600000	shares
CY2022	AVNI	Conversion Of Related Party Debt To Equity ConversionOfRelatedPartyDebtToEquity	40000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	29713	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-151396	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	104495	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	249952	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1316573	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-962126	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1316573	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-151396	usd
CY2023	us-gaap	Depreciation Depreciation	23969	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	249952	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	29713	usd
CY2023	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	771009	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	65525	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2061	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-206118	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-133328	usd
CY2023	AVNI	Payments To Acquire Fixed Assets PaymentsToAcquireFixedAssets	-8641	usd
CY2023	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	50000	usd
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	-0	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-4089	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-54552	usd
CY2023	AVNI	Proceeds From Loans Payable ProceedsFromLoansPayable	123266	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3340	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22071	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	142365	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	12625	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	AVNI	Related Party Payable Reduced Through Issuance Of Shares RelatedPartyPayableReducedThroughIssuanceOfShares	40000	usd
CY2023	AVNI	Acquisition Acquisition	700000	usd
CY2022	AVNI	Acquisition Acquisition	0	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	234904	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zHzQCQx1JL93" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_86A_z5JmcVa4cg5n" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates include the recognition of deferred tax assets based on the change in unrecognized deductible temporary tax differences.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zWtxXgF1SYGb" style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_86F_z7qlc3SkKPUH" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Concentration of Credit Risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash. The Company maintains cash in bank accounts that, at times, may exceed federally insured limits. At December 31, 2023 and December 31, 2022 respectively, the Company did not have any cash in excess of the insured FDIC limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risks on its cash in bank account.</span></p>
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7950000	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1316573	usd
CY2023	AVNI	Cash Flow From Operating Activities CashFlowFromOperatingActivities	-118652	usd
CY2023Q4	AVNI	Working Capital WorkingCapital	311316	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37556941	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1316573	usd
CY2023	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	771009	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	4089	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	5100	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	178706	usd
CY2023Q1	AVNI	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Commercial Fishing License BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCommercialFishingLicense	26000	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	213895	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	4910	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	644	usd
CY2023Q1	AVNI	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Payable To Affiliates BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayableToAffiliates	62634	usd
CY2023Q1	AVNI	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Notes Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable	166716	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	234904	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	750000	usd
CY2023Q1	AVNI	Business Combination Loss On Asset Acquisition BusinessCombinationLossOnAssetAcquisition	771009	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	187347	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	0	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23969	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	-0	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	163378	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	0	usd
CY2023	us-gaap	Depreciation Depreciation	23969	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	4000	usd
CY2023	us-gaap	Lease Income LeaseIncome	44000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	48000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	48000	usd
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	4800000	shares
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.07
CY2022Q4	AVNI	Restricted Common Stock Total Proceeds RestrictedCommonStockTotalProceeds	320000	usd
CY2022	AVNI	Incurred Share Issuance Costs IncurredShareIssuanceCosts	-32237	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	107845554	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	107845554	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	107839299	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	107839299	shares
CY2023Q4	AVNI	Accrued Payroll Included In Amounts Due To Related Parties AccruedPayrollIncludedInAmountsDueToRelatedParties	30000	usd
CY2022Q4	AVNI	Accrued Payroll Included In Amounts Due To Related Parties AccruedPayrollIncludedInAmountsDueToRelatedParties	7500	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1200	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	600	usd
CY2023	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties	15000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7950000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.09
CY2023Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	249952	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29713	usd
CY2023	AVNI	Allocated Share Based Compensation Expense Remaining AllocatedShareBasedCompensationExpenseRemaining	410224	usd
CY2024Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	239421	shares
CY2025Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	156902	shares
CY2026Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	7582	shares
CY2027Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	6319	shares
CY2023	AVNI	Allocated Share Based Compensation Expense Remaining AllocatedShareBasedCompensationExpenseRemaining	410224	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	919626	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	0	usd
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	79438	usd
CY2023Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	840188	usd
CY2022Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	79438	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	711051	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	11864	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	10568	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	6934	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive	99771	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	919626	usd
CY2024Q1	AVNI	Notes Payable Related Parties NotesPayableRelatedParties	20000	usd
CY2024Q1	AVNI	Notes Receivable Related Party NotesReceivableRelatedParty	300000	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	132000	usd

Files In Submission

Name	View Source	Status
0001607062-24-000118-index-headers.html	Edgar Link	pending
0001607062-24-000118-index.html	Edgar Link	pending
0001607062-24-000118.txt	Edgar Link	pending
0001607062-24-000118-xbrl.zip	Edgar Link	pending
avni-20231231.xsd	Edgar Link	pending
avni123123form10k.htm	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
avni-20231231_def.xml	Edgar Link	unprocessable
avni-20231231_lab.xml	Edgar Link	unprocessable
avni-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
avni123123form10k_htm.xml	Edgar Link	completed
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
avni-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AVNI
ARVANA INC Stock $avni

2024 Q2 Form 10-K Financial Statement

#000160706224000118 Filed on April 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVNI ARVANA INC Stock $avni

2024 Q2 Form 10-K Financial Statement

#000160706224000118 Filed on April 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVNI
ARVANA INC Stock $avni